ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 30915 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 30915; 2) Community: the network communities that were significantly associated with the response to NSC 30915; 3) Molecule: the relationships between components within communities and NSC 30915; 4) MDR: the compounds that were significantly associated with the NSC 30915.

NSC Compound Enrichment Correlation
NSC 755523 Null 0.000216242727122389 0.35101564
NSC 622294 Null 0.000281397700245217 0.23472723
NSC 711661 Null 0.000285499812229894 0.23634863
NSC 746701 N-(4-Chlorophenyl)-N-({[2-(4-chlorophenyl)ethyl]amino]carbonothioyl)benzamide 0.000380874609232502 0.49759157
NSC 335753 HELIANGOLIDE 0.000385746291616526 0.65689944
NSC 699669 Null 0.000385746291616526 0.70937326
NSC 699936 Null 0.000385746291616526 0.65196383
NSC 295426 Propanoic acid, 2-methyl-, 2,3,3a,4,5,8,9,11a-octahydro-6,10-bis(hydroxymethyl)-3-methylene-2-oxocyclodeca[b]furan-4-yl ester, [3aR-(3aR*,4S*,6Z,10Z,11aR*)]- (9CI) 0.000385746291616529 0.58252227
NSC 639501 Cyclopentanone, 2-pentylidene-5-[(1-piperidinyl)methyl]- hydrochloride 0.000416103361609065 0.3972014
NSC 661581 2-Azabicyclo[16.3.1]docosane, geldanamycin deriv. 0.000416103361609065 0.66074163
Total:84  Current:2    [First] [Prev] [Next] [Last]